Dezert Tablet

About Dezert 6 mg Tablet

Dezert 6 mg Tablet contains deflazacort, a glucocorticoid that reduces inflammation and suppresses immune reactions. It is used for allergic, inflammatory and autoimmune conditions as directed by a doctor.

There are 28 brands of Deflazacort listed in Bangladesh. By unit price, Dezert is among the cheapest of them.

What is Dezert 6 mg Tablet?

Dezert 6 mg Tablet is a glucocorticoid medicine. It works by blocking an enzyme involved in inflammation and by reducing the release of immune system chemicals. This helps control swelling, allergic reactions, and autoimmune activity. Doctors prescribe it for conditions such as severe asthma, rheumatoid arthritis, lupus, and skin disorders. The dose and course are always set by the doctor based on the condition. Dezert is available as a 6 mg tablet in a pack of 3 x 10 tablets. It should be stored properly and kept out of reach of children.

Uses of Dezert

Dezert 6 mg Tablet is used to treat a range of conditions where inflammation or immune activity plays a role. These include severe allergic reactions, asthma, rheumatoid arthritis, juvenile arthritis, lupus, and other connective tissue diseases. It is also used for certain skin conditions like pemphigus. Your doctor will decide if this medicine is suitable for you.

How to use Dezert

Take Dezert 6 mg Tablet exactly as your doctor tells you. The dose and how long you take it depend on your condition. Do not change the dose or stop taking it without talking to your doctor, as stopping suddenly can cause problems. Swallow the tablet with water. If you miss a dose, ask your doctor or pharmacist for advice on what to do.

Side effects of Dezert

Like all medicines, Dezert 6 mg Tablet can cause side effects. Common ones include stomach upset, muscle and bone problems, and changes in mood or sleep. It can also affect blood sugar, blood pressure, and increase the risk of infection. Some people may notice skin thinning or acne. Tell your doctor if you experience any side effects, especially if they bother you or do not go away.

Safety and precautions

Before taking Dezert 6 mg Tablet, tell your doctor if you have heart disease, high blood pressure, diabetes, stomach ulcers, or an infection. This medicine can hide signs of infection and may not be suitable if you have recently had a live vaccine. If you are pregnant, planning to become pregnant, or breastfeeding, speak to your doctor first. Corticosteroids may affect the baby, so the doctor will weigh the benefits and risks.

Frequently asked questions

What is Dezert 6 mg Tablet used for and what kind of medicine is it?

Dezert 6 mg Tablet is a glucocorticoid, a type of steroid medicine. It is used to reduce inflammation and suppress the immune system in conditions like severe allergies, asthma, arthritis, and lupus. Your doctor will determine if it is right for you.

How should I store Dezert 6 mg Tablet?

Store Dezert 6 mg Tablet in a cool, dry place below 25°C, away from light and moisture. Keep the tablets out of the reach of children. Do not use after the expiry date printed on the pack.

What does the generic name deflazacort mean?

Deflazacort is the generic name of the active ingredient in Dezert 6 mg Tablet. It is a synthetic glucocorticoid, which means it is a man-made version of a hormone your body produces naturally to control inflammation and immune responses.

What is the price of Dezert 6 mg Tablet?

The listed price is ৳ 8.00.

Indications

Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • ... Read more
Deflazacort is indicated in-
  • Anaphylaxis, asthma, severe hypersensitivity reactions
  • Rheumatoid arthritis, juvenile chronic arthritis, polymyalgia rheumatica
  • Systemic lupus erythematosus, dermatomyositis, mixed connective tissue disease (other than systemic sclerosis), polyartritis nodosa, sarcoidosis
  • Pemphigus,bullous pemphigoid, pyoderma gangrenosum
  • Minimal change nephrotic syndrome, acute interstitial nephritis
  • Rheumatic carditis
  • Ulcerative colitis, Crohn's disease
  • Uveitis, optic neuritis
  • Autoimmune haemolytic anaemia, idiopathic thrombocytopenic purpura
  • Acute and lymphatic leukaemia, malignant lymphoma, multiple myeloma
  • Immune suppression in transplantation

Pharmacology

Deflazacort provides anti-inflammatory action by inhibiting Phospholipase A2 enzyme which is responsible for prostaglandin synthesis. Besides Deflazacort decreases the release of certain chemicals that are important in the immune system. By decreasing the release of these chemicals Deflazacort provides immunosuppressive action.

Dosage & Administration

Adults-
  • For acute disorders: Up to 120 mg/day Deflazacort may need to be given initially. Maintenance doses in most conditions are within the range of 3-18 mg/day.
  • Rheumatoid arthritis: The maintenance dose is usually within the range of 3-18 mg/day. The smallest effective dose should be used and increased if necessary.
  • Bronchial asthma: In the treatment of an acute attack, high doses of 48-72 mg/day may be needed depending on severity and gradually reduced once the attack has been controlled. For maintenance in chronic asthma, doses should be titrated to the lowest dose that controls symptoms.
  • Other conditions: The dose of Deflazacort depends on clinical need titrated to the lowest effective dose for maintenance. Starting doses may be estimated on the basis of ratio of 5 mg prednisone or prednisolone to 6 mg.
Children: There has been limited exposure of children to Deflazacort in clinical trials. In children, the indications for glucocorticoids arethe same as for adults, but it is important that the lowest effective dosage is used. Alternate day administration may be appropriate. Doses of Deflazacort usually lie in the range 0.25-1.5 mg/kg/day.

The following ranges provide general guidance:
  • Juvenile chronic arthritis: The usual maintenance dose is between 0.25-1.0 mg/kg/day.
  • Nephrotic syndrome: Initial dose of usually 1.5 mg/kg/day followed by down titration according to clinical need.
  • Bronchial asthma: On the basis of the potency ratio, the initial dose should be between 0.25-1.0 mg/kg on alternate days.
Deflazacort withdrawal: In patients who have received more than physiological doses of systemic corticosteroids (approximately 9 mg per day or equivalent) for greater than 3 weeks, withdrawal should not be abrupt. How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced.

Interaction

Deflazacort is metabolized in the liver. It is recommended to increase the maintenance dose of Deflazacort if drugs which are liver enzyme inducers are co-administered, e.g. rifampicin, rifabutin, carbamazepine, phenobarbitone, phenytoin, primidone and aminoglutethimide. For drugs which inhibit liver enzymes, (e.g. ketoconazole) it may be possible to reduce the maintenance dose of Deflazacort.

Contraindications

Hypersensitivity to or any of the ingredients. Patients receiving live virus immunization.

Side Effects

GI disturbances, musculoskeletal, endocrine, neuropsychiatric, ophthalmic, fluid and electrolyte disturbances; susceptible to infection, impaired healing, hypersensitivity, skin atrophy, striae, telangiectasia, acne, myocardial rupture following recent Ml, thromboembolism.

Pregnancy & Lactation

Pregnancy: Deflazacort does cross the placenta. However, when administered for prolonged periods or repeatedly during pregnancy, corticosteroids may increase the risk of intrauterine growth retardation. As with all drugs, corticosteroids should only be prescribed when the benefits to the mother and child outweigh the risks.

Nursing Mother: Corticosteroids are excreted in breast milk, although no data are available for Deflazacort. Doses of up to 50 mg daily of Deflazacort are unlikely to cause systemic effects in the infant. Infants of mothers taking higher doses than this may have a degree of adrenal suppression but the benefits of breastfeeding are likely to outweigh any theoretical risk.

Precautions & Warnings

The following clinical conditions require special caution and frequent patient monitoring is necessary-
  • Cardiac disease or congestive heart failure (except in the presence of active rheumatic carditis), hypertension, thromboembolic disorders. Glucocorticoids can cause salt and water retention and increased excretion of potassium. Dietary salt restriction and potassium supplementation may be necessary.
  • Gastritis or oesophagitis, diverticulitis, ulcerative colitis if there is the probability of impending perforation, abscess or pyogenic infections, fresh intestinal anastomosis, active or latent peptic ulcer.
  • Diabetes mellitus or family history, osteoporosis, myasthenia gravis, renal insufficiency.
  • Emotional instability or psychotic tendency, epilepsy.
  • Previous corticosteroid-induced myopathy.
  • Liver failure.
  • Hypothyroidism and cirrhosis, which may increase the glucocorticoid effect.
  • Ocular herpes simplex because of possible corneal perforation.

Storage Conditions

Store in a cool (below 25°C) and dry place, protected from light & moisture. Keep out of the reach of children.

Alternative brands of Deflazacort

Other brands with the same generic name, cheapest first.

See all 28 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.